The global US Plasma Fractionation Market is projected to reach US$13.80 billion by 2028 from US$10.13 billion in 2023, at a ...

The global US Plasma Fractionation Market  is projected to reach US$13.80 billion by 2028 from US$10.13 billion in 2023, at a CAGR of 6.4% during the forecast period. The increasing use of ...

Sheldon Ekirch spends a lot of time on hold with her health insurance company. Sometimes, as the minutes tick by and her frustration mounts, Ekirch, 30, opens a meditation app on her phone. It was ...

Intravenous immunoglobulin (IVIG) is one treatment option. Crohn’s disease is a type of inflammatory bowel disease (IBD) that affects an estimated a million people in the United States.

The study has two study groups. One group will receive intravenous immunoglobulins (IVIG), which contains antibodies to help the body fight infection, or a placebo, and the other ivabradine, an oral ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profileof VYVGART and VYVGART Hytrulo gMG patients on VYVGART achieve rapid, substantial, and sustained efficacy ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

Nearly 28 years have passed, and the Grand Theft Auto (GTA) franchise has consistently maintained its core identity, which is reflected even in its logos. While the highly anticipated next installment ...